In one of the major bipartisan accords of the year, the House in July passed the 21st Century Cures Act, a bill that overhauls the drug and medical device approval process with the aim of speeding innovation and finding faster cures for diseases.
The bill won House approval by an overwhelming 344 to 77, with lawmakers on both sides of the aisle backing it.
The bill, Democratic caucus Chairman Xavier Becerra, D-Calif., said at the time, “gives us a fighting chance to achieve those breakthrough discoveries or life-saving treatments in time to reach your loved one or mine.”
But in the Senate, lawmakers have hit the “pause” button on the Cures Act.
Congress is poised to adjourn for the year, and the legislation is nowhere to be found on the Senate schedule.